BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 35563015)

  • 1. Acute T-Cell-Driven Inflammation Requires the Endoglycosidase Heparanase-1 from Multiple Cell Types.
    Wu Z; Sweet RA; Hoyne GF; Simeonovic CJ; Parish CR
    Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of the heparan sulfate-degrading enzyme heparanase is induced in infiltrating CD4+ T cells in experimental autoimmune encephalomyelitis and regulated at the level of transcription by early growth response gene 1.
    de Mestre AM; Staykova MA; Hornby JR; Willenborg DO; Hulett MD
    J Leukoc Biol; 2007 Nov; 82(5):1289-300. PubMed ID: 17656651
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heparanase degrades syndecan-1 and perlecan heparan sulfate: functional implications for tumor cell invasion.
    Reiland J; Sanderson RD; Waguespack M; Barker SA; Long R; Carson DD; Marchetti D
    J Biol Chem; 2004 Feb; 279(9):8047-55. PubMed ID: 14630925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Unexpected new roles for heparanase in Type 1 diabetes and immune gene regulation.
    Parish CR; Freeman C; Ziolkowski AF; He YQ; Sutcliffe EL; Zafar A; Rao S; Simeonovic CJ
    Matrix Biol; 2013 Jun; 32(5):228-33. PubMed ID: 23499527
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Uptake of Heparanase into Mast Cells Is Regulated by Its Enzymatic Activity to Degrade Heparan Sulfate.
    Shi J; Onuki Y; Kawanami F; Miyagawa N; Iwasaki F; Tsuda H; Takahashi K; Oku T; Suzuki M; Higashi K; Adachi H; Nishimura Y; Nakajima M; Irimura T; Higashi N
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Heparanase: Historical Aspects and Future Perspectives.
    Khanna M; Parish CR
    Adv Exp Med Biol; 2020; 1221():71-96. PubMed ID: 32274707
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chondroitin sulfate E blocks enzymatic action of heparanase and heparanase-induced cellular responses.
    Higashi N; Maeda R; Sesoko N; Isono M; Ishikawa S; Tani Y; Takahashi K; Oku T; Higashi K; Onishi S; Nakajima M; Irimura T
    Biochem Biophys Res Commun; 2019 Nov; 520(1):152-158. PubMed ID: 31582210
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemical toolbox to interrogate Heparanase-1 activity.
    Rabinowitz ZM; Somers J; Wang Z; Cui L
    Curr Opin Chem Biol; 2024 Jun; 80():102452. PubMed ID: 38555836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An Overview of the Structure, Mechanism and Specificity of Human Heparanase.
    Wu L; Davies GJ
    Adv Exp Med Biol; 2020; 1221():139-167. PubMed ID: 32274709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recent data concerning heparanase: focus on fibrosis, inflammation and cancer.
    Secchi MF; Masola V; Zaza G; Lupo A; Gambaro G; Onisto M
    Biomol Concepts; 2015 Dec; 6(5-6):415-21. PubMed ID: 26552066
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-reducing end labeling of heparan sulfate via click chemistry and a high throughput ELISA assay for heparanase.
    Wu ZL; Huang X; Ethen CM; Tatge T; Pasek M; Zaia J
    Glycobiology; 2017 Jun; 27(6):518-524. PubMed ID: 28025251
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heparanase and autoimmune diabetes.
    Simeonovic CJ; Ziolkowski AF; Wu Z; Choong FJ; Freeman C; Parish CR
    Front Immunol; 2013 Dec; 4():471. PubMed ID: 24421779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Regulatory T cells use heparanase to access IL-2 bound to extracellular matrix in inflamed tissue.
    Martinez HA; Koliesnik I; Kaber G; Reid JK; Nagy N; Barlow G; Falk BA; Medina CO; Hargil A; Zihsler S; Vlodavsky I; Li JP; Pérez-Cruz M; Tang SW; Meyer EH; Wrenshall LE; Lord JD; Garcia KC; Palmer TD; Steinman L; Nepom GT; Wight TN; Bollyky PL; Kuipers HF
    Nat Commun; 2024 Feb; 15(1):1564. PubMed ID: 38378682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation.
    Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z
    Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Crosstalk between tumor cells and lymphocytes modulates heparanase expression.
    Theodoro TR; Matos LL; Cavalheiro RP; Justo GZ; Nader HB; Pinhal MAS
    J Transl Med; 2019 Mar; 17(1):103. PubMed ID: 30922347
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of mouse Heparanase gene expression in T lymphocytes and tumor cells.
    de Mestre AM; Soe-Htwe T; Sutcliffe EL; Rao S; Pagler EB; Hornby JR; Hulett MD
    Immunol Cell Biol; 2007; 85(3):205-14. PubMed ID: 17213834
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Discovery and development of small-molecule heparanase inhibitors.
    Zhang Y; Cui L
    Bioorg Med Chem; 2023 Jul; 90():117335. PubMed ID: 37257254
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pro-Angiogenic Effects of Latent Heparanase and Thrombin Receptor-Mediated Pathways-Do They Share a Common Ground in Melanoma Cells?
    Hoß SG; Grundmann M; Benkel T; Gockel L; Schwarz S; Kostenis E; Schlesinger M; Ilan N; Vlodavsky I; Bendas G
    Thromb Haemost; 2018 Oct; 118(10):1803-1814. PubMed ID: 30235481
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heparanase and a synthetic peptide of heparan sulfate-interacting protein recognize common sites on cell surface and extracellular matrix heparan sulfate.
    Marchetti D; Liu S; Spohn WC; Carson DD
    J Biol Chem; 1997 Jun; 272(25):15891-7. PubMed ID: 9188488
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cell surface heparan sulfate released by heparanase promotes melanoma cell migration and angiogenesis.
    Roy M; Marchetti D
    J Cell Biochem; 2009 Feb; 106(2):200-9. PubMed ID: 19115257
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.